181 related articles for article (PubMed ID: 16487435)
21. [Influence of the APOE genotypes in some atherosclerotic risk factors].
Carmo Martins M; Lima Faleiro L; Rodrigues MO; Albergaria I; Fonseca A
Acta Med Port; 2008; 21(5):433-40. PubMed ID: 19187685
[TBL] [Abstract][Full Text] [Related]
22. Associations between apolipoprotein E gene polymorphism and plasminogen activator inhibitor-1 and atherogenic lipid profile in dialysis patients.
Arikan H; Koc M; Sari H; Tuglular S; Ozener C; Akoglu E
Ren Fail; 2007; 29(6):713-9. PubMed ID: 17763167
[TBL] [Abstract][Full Text] [Related]
23. The significant increase in cardiovascular disease risk in APOEepsilon4 carriers is evident only in men who smoke: potential relationship between reduced antioxidant status and ApoE4.
Talmud PJ; Stephens JW; Hawe E; Demissie S; Cupples LA; Hurel SJ; Humphries SE; Ordovas JM
Ann Hum Genet; 2005 Nov; 69(Pt 6):613-22. PubMed ID: 16266401
[TBL] [Abstract][Full Text] [Related]
24. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene".
Gerdes LU; Jeune B; Ranberg KA; Nybo H; Vaupel JW
Genet Epidemiol; 2000 Oct; 19(3):202-10. PubMed ID: 11015124
[TBL] [Abstract][Full Text] [Related]
25. [Age-related macular degeneration: its association with the epsilon4 allele of the apolipoprotein E gene].
Asensio-Sánchez VM; Rodríguez-Martín T; Gala-Molina I; Rodríguez-Fernández I
Arch Soc Esp Oftalmol; 2006 Jan; 81(1):9-12. PubMed ID: 16450255
[TBL] [Abstract][Full Text] [Related]
26. [Relationship between blood lipid level and apolipoprotein E gene polymorphism in offspring from longevity and non-longevity families].
Wang X; Sun J; Wang G; Ye G
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 May; 34(3):159-61. PubMed ID: 11860925
[TBL] [Abstract][Full Text] [Related]
27. Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.
Elovainio M; Puttonen S; Pulkki-Råback L; Kivimaki M; Viiri LE; Lehtimaki T; Karhunen P; Viikari J; Raitakari OT; Keltikangas-Jarvinen L
Neuropsychobiology; 2008; 58(2):91-6. PubMed ID: 18843194
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 6-174 G/C promoter gene polymorphism in centenarians: no evidence of association with human longevity or interaction with apolipoprotein E alleles.
Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Capurso SA; Semeraro C; Capurso A; Panza F
Exp Gerontol; 2004 Jul; 39(7):1109-14. PubMed ID: 15236771
[TBL] [Abstract][Full Text] [Related]
29. Association between apolipoprotein E polymorphism and serum lipid and apolipoprotein levels with Alzheimer's disease.
Raygani AV; Rahimi Z; Kharazi H; Tavilani H; Pourmotabbed T
Neurosci Lett; 2006 Nov; 408(1):68-72. PubMed ID: 16997467
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
Tziakas DN; Chalikias GK; Antonoglou CO; Veletza S; Tentes IK; Kortsaris AX; Hatseras DI; Kaski JC
J Am Coll Cardiol; 2006 Dec; 48(12):2471-81. PubMed ID: 17174184
[TBL] [Abstract][Full Text] [Related]
31. [Genetic polymorphism of the E apolipoprotein in school age children: comparison with levels of plasma lipids and apolipoproteins].
Callas N; Poveda E; Baracaldo C; Hernández P; Castillo C; Guerra M
Biomedica; 2007 Dec; 27(4):526-36. PubMed ID: 18320120
[TBL] [Abstract][Full Text] [Related]
32. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity.
Johansson LE; Danielsson P; Norgren S; Marcus C; Ridderstråle M
Int J Pediatr Obes; 2009; 4(2):119-25. PubMed ID: 18645733
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of apolipoprotein E and risk of stroke in old age.
van Vliet P; Mooijaart SP; de Craen AJ; Rensen PC; van Heemst D; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():140-7. PubMed ID: 17460172
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E genotypes and their relation to lipid levels in a rural South African population.
Masemola ML; Alberts M; Urdal P
Scand J Public Health Suppl; 2007 Aug; 69():60-5. PubMed ID: 17676504
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E gene polymorphism and its association with human longevity in the Uygur nationality in Xinjiang.
Wang X; Wang G; Yang C; Li X
Chin Med J (Engl); 2001 Aug; 114(8):817-20. PubMed ID: 11780357
[TBL] [Abstract][Full Text] [Related]
36. Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study.
Eiriksdottir G; Aspelund T; Bjarnadottir K; Olafsdottir E; Gudnason V; Launer LJ; Harris TB
Atherosclerosis; 2006 May; 186(1):222-4. PubMed ID: 16445917
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein E polymorphism and coronary heart disease.
Ashavaid TF; Todur SP; Nair KG
J Assoc Physicians India; 2003 Aug; 51():784-8. PubMed ID: 14651139
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
[TBL] [Abstract][Full Text] [Related]
39. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
40. Microcrystalline chitosan is ineffective to decrease plasma lipids in both apolipoprotein E epsilon 4 carriers and non-carriers: a long-term placebo-controlled trial in hypercholesterolaemic volunteers.
Lehtimäki T; Metso S; Ylitalo R; Rontu R; Nikkilä M; Wuolijoki E; Ylitalo P
Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):98-103. PubMed ID: 15998356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
